Daniel James George, MD

Professor of Medicine
Professor in Surgery
Member of the Duke Cancer Institute
Campus mail Duke Box 103861, Durham, NC 27710
Phone (919) 668-4615
Email address daniel.george@duke.edu
In Their Words

Education and Training

  • Fellow in Medical Oncology, Medicine, Johns Hopkins University, 1995 - 1998
  • Medical Resident, Medicine, Johns Hopkins University, 1992 - 1995
  • M.D., Duke University, 1992

Publications

Bakthavatsalam, S, Sleeper, ML, Dharani, A, George, DJ, Zhang, T, and Franz, KJ. "Leveraging gamma-glutamyl transferase to direct cytotoxicity of copper dithiocarbamates against prostate cancer cells." Angewandte Chemie (International Ed. in English) (July 19, 2018).

PMID
30025197
Full Text

LaCroix, BL, Patierno, BM, Sullenger, BA, George, DJ, Patierno, SR, and Freedman, JA. "Development of a novel therapeutic splice-switching oligonucleotide targeting race-related androgen receptor signaling and aggressive prostate cancer." 10th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved. Atlanta, GA. September 25, 2017 - September 28, 2017.: AMER ASSOC CANCER RESEARCH, July 1, 2018.

Scholars@Duke

LaCroix, BL, Patierno, BM, Sullenger, BA, George, DJ, Patierno, SR, and Freedman, JA. "Nutritional profiling reveals glutamine-utilizing transaminases as a metabolic vulnerability of TAZ/YAP-driven breast cancer cells." 10th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved. Atlanta, GA. September 25, 2017 - September 28, 2017.: AMER ASSOC CANCER RESEARCH, July 1, 2018.

Scholars@Duke

Freedman, JA, Wang, Y, Li, X, Liu, H, Moorman, PG, George, DJ, Lee, NH, Hyslop, T, Wei, Q, and Patierno, SR. "Single-nucleotide polymorphisms of stemness genes predicted to regulate RNA splicing, microRNA and oncogenic signaling are associated with prostate cancer survival." Carcinogenesis 39, no. 7 (July 2018): 879-888.

PMID
29726910
Full Text

Labriola, M, Foo, W-C, George, DJ, and Zhang, T. "Pazopanib in the Treatment of Bilateral Multifocal Renal Oncocytomas: A Case Report." Clinical Genitourinary Cancer 16, no. 3 (June 2018): e509-e512.

PMID
29636282
Full Text

Slovin, S, Clark, W, Carles, J, Krivoshik, A, Park, JW, Wang, F, and George, D. "Seizure Rates in Enzalutamide-Treated Men With Metastatic Castration-Resistant Prostate Cancer and Risk of Seizure: The UPWARD Study." Jama Oncology 4, no. 5 (May 2018): 702-706.

PMID
29222530
Full Text

Choueiri, TK, Hessel, C, Halabi, S, Sanford, B, Michaelson, MD, Hahn, O, Walsh, M, Olencki, T, Picus, J, Small, EJ, Dakhil, S, Feldman, DR, Mangeshkar, M, Scheffold, C, George, D, and Morris, MJ. "Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update." European Journal of Cancer (Oxford, England : 1990) 94 (May 2018): 115-125.

PMID
29550566
Full Text

Gao, X, Jegede, O, Gray, C, Catalano, PJ, Novak, J, Kwiatkowski, DJ, McKay, RR, George, DJ, Choueiri, TK, McDermott, DF, Signoretti, S, and Bhatt, RS. "Comprehensive Genomic Profiling of Metastatic Tumors in a Phase 2 Biomarker Study of Everolimus in Advanced Renal Cell Carcinoma." Clinical Genitourinary Cancer (April 25, 2018).

PMID
29754934
Full Text

Humeniuk, MS, Gupta, RT, Healy, P, McNamara, M, Ramalingam, S, Harrison, M, George, D, Zhang, T, Wu, Y, and Armstrong, AJ. "Platinum sensitivity in metastatic prostate cancer: does histology matter?." Prostate Cancer and Prostatic Diseases 21, no. 1 (April 2018): 92-99.

PMID
29230006
Full Text

Clarke, JM, George, DJ, Lisi, S, and Salama, AKS. "Immune Checkpoint Blockade: The New Frontier in Cancer Treatment." Targeted oncology 13, no. 1 (February 13, 2018): 1-20.

PMID
29441437
Full Text

Pages